InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.34
(
0.44%
)
Bitcoin
68,438.40
(
-0.11%
)
Post# of 923
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rarefind

Send PM Follow Ignore
Followers 165
Posts 13286
Boards Moderated 0
Alias Born 03/06/2011

rarefind

Re: otterman post# 844

Monday, 08/06/2012 3:50:12 PM

Monday, August 06, 2012 3:50:12 PM

Post# of 923
YM BioSciences, Inc. (AMEX:YMI): After Incyte (NASDAQ:INCY) reported high initial levels of patient discontinuations in a study of Jakafi for myelofibrosis, YM Biosciences shares, which has a similar drug, fell on Friday, according to JMP Securities. The firm thinks that YM Biosciences’ drug could be better suited for patients with anemia. The firm keeps and Outperform rating and a $5 target on the stock.

All my posts are my OPINION>>IMO>>>Do your own Due Diligence!!.......rareF...deal with it

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!